DERMAZOLE 500 Tablet is an advanced antifungal pharmaceutical product that contains Griseofulvin in a 500 mg oral dosage form. Griseofulvin is a well-established antifungal medication that has been in clinical use for decades and remains a cornerstone treatment for tinea infections, also known as ringworm infections. These include tinea corporis (body), tinea capitis (scalp), tinea pedis (feet), tinea cruris (groin), and tinea unguium (nails).
DERMAZOLE 500 is produced by BluepillExpress, a reputed Indian pharmaceutical company specializing in third-party manufacturing and global export of quality medicines. The product is manufactured in WHO-GMP and ISO-certified facilities, ensuring high quality, safety, and efficacy. With global regulatory support, BluepillExpress offers DERMAZOLE 500 to pharmaceutical brands and distributors seeking dependable antifungal solutions across emerging and developed markets.
Mechanism of Action
Griseofulvin, the active ingredient in DERMAZOLE 500, exerts its antifungal effect by disrupting the mitotic spindle structure in fungal cells, which inhibits cell division and reproduction. It also binds to keratin in human cells, making the newly formed skin, hair, and nails resistant to fungal invasion. The drug accumulates in these keratin-rich tissues and remains effective for long durations, ensuring continuous antifungal protection during and even after treatment.
Indications
DERMAZOLE 500 is indicated for:
Tinea corporis (ringworm of the body)
Tinea capitis (ringworm of the scalp)
Tinea pedis (athlete’s foot)
Tinea cruris (jock itch)
Tinea unguium (onychomycosis or fungal nail infection)
Tinea barbae (fungal beard infections)
Other dermatophyte-related fungal infections of the skin, hair, and nails unresponsive to topical agents
It is particularly used when the extent of infection is large, recurrent, or has involved hair and nail tissues that topical medications cannot effectively reach.
Description provided by bluepill express.
FIEO Registered
Export Ready
